세계의 결절성 양진 치료 시장 보고서(2025년)

Prurigo Nodularis Treatment Global Market Report 2025

US $ 4,490 ￦ 6,233,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,010,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,786,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

결절성 양진 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 5.1%의 CAGR로 21억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 의료비 지출 증가, 결절성 양진에 대한 인식 개선, 표적 치료제에 대한 수요 증가, 연구개발 활동 증가, 새로운 치료법 승인 증가 등에 기인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 생물학적 치료의 발전, 피부질환 진단 접근법 개선, 국소 치료제의 혁신, 원격 피부과 서비스의 통합, 환자 중심의 첨단 치료 모델 개발 등이 있습니다.

만성 피부 질환의 유병률 증가는 향후 몇 년 동안 결절성 양진 치료 시장의 성장을 견인할 것으로 예상됩니다. 만성 피부질환은 장기적이거나 반복적인 피부 질환으로 지속적인 관리가 필요한 경우가 많아 환자의 삶의 질에 큰 영향을 미칠 수 있습니다. 이러한 질환의 증가는 환경 오염 물질에 대한 노출 증가에 기인하며, 환경 오염 물질은 피부의 자연 장벽을 손상시키고 지속적인 염증을 유발할 수 있습니다. 결절성 양진 치료는 지속적인 가려움증과 피부 병변을 유발하는 염증 경로를 표적으로 삼아 만성 피부 질환의 근본적인 원인을 해결하는 데 초점을 맞추고 있습니다. 이러한 치료법은 면역 체계의 과잉 활동을 제어함으로써 결절성 양진 환자의 증상을 효과적으로 완화하고 삶의 질을 개선할 수 있습니다. 예를 들어, 2023년 7월 영국의 자선단체인 Office of Health Economics(OHE)는 영국에서 최소 20만 명이 고통스러운 만성 피부질환인 농포성 땀샘염(HS)을 앓고 있으며, 연간 38억 3,000만 파운드(약 43억 5,000만 달러)로 추정된다고 보고했습니다. 따라서 만성 피부질환의 발생률 증가가 결절성 양진 치료 시장의 성장에 기여하고 있습니다.

결절성 양진 치료 시장의 주요 업체들은 특정 면역 경로를 표적으로 삼아 보다 효과적인 증상 완화를 목표로 하는 단클론항체를 포함한 혁신적인 치료법을 개발하는 데 주력하고 있습니다. 단클론항체는 바이러스를 포함한 유해한 병원체와 싸우는 면역계의 자연적 능력을 복제하도록 설계된 합성 분자입니다. 예를 들어, 2024년 8월 스위스 제약사 가르델마는 미국 식품의약국(FDA)이 성인 결절성 양진 환자의 치료제로 네므비오(네모리주맙)를 승인했다고 발표했습니다. 이번 승인은 Nemurvio가 가려움증 강도와 피부 결절의 현저한 개선을 보인 OLYMPIA 임상시험의 유망한 결과에 따른 것입니다. 이 치료제는 결절성 양진 증상을 유발하는 데 중요한 역할을 하는 IL-31 신호를 특이적으로 표적으로 삼습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 결절성 양진 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 결절성 양진 치료 시장 : 성장률 분석
• 세계의 결절성 양진 치료 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 결절성 양진 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 결절성 양진 치료 전체 시장(TAM)

제6장 시장 세분화

• 세계의 결절성 양진 치료 시장 : 치료법별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 의약품
• 냉동요법
• 광선요법
• 펄스 색소 레이저
• 기타 치료법
• 세계의 결절성 양진 치료 시장 : 진단별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 피부 생검
• 혈액 검사
• 기타
• 세계의 결절성 양진 치료 시장 : 투여 경로별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 국소 투여
• 경구 투여
• 비경구 투여
• 세계의 결절성 양진 치료 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원 약국
• 소매 약국
• 온라인 약국
• 세계의 결절성 양진 치료 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 클리닉
• 병원
• 기타
• 세계의 결절성 양진 치료 시장, 의약품 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 국소 코르티코스테로이드
• 항히스타민제
• 면역억제제
• 신경조절제
• 생물학적요법
• 세계의 결절성 양진 치료 시장, 냉동요법 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 액체 질소 적용
• 스프레이 동결 기술
• 동결 프로브 요법
• 세계의 결절성 양진 치료 시장, 광선요법 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 협대역 자외선 B(NB-UVB)
• 광대역 자외선 B(BB-UVB)
• 소랄렌 플러스 자외선 A(PUVA)
• 세계의 결절성 양진 치료 시장, 펄스 색소 레이저 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 585 나노미터(nm) 파장 요법
• 595 나노미터(nm) 파장 요법
• 세계의 결절성 양진 치료 시장, 기타 치료법 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 행동치료
• 침
• 연화제와 보습제
• 외과적 절제

제7장 지역별·국가별 분석

• 세계의 결절성 양진 치료 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 결절성 양진 치료 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 결절성 양진 치료 시장 : 경쟁 구도
• 결절성 양진 치료 시장 : 기업 개요
  • Roche Holding AG
  • Sanofi S.A.
  • Amgen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Galderma S.A

제31장 기타 주요 기업과 혁신적 기업

• Incyte Corporation
• LEO Pharma A/S
• Almirall S.A.
• Maruho Co. Ltd.
• VYNE Therapeutics Inc.
• Kiniksa Pharmaceuticals Ltd.
• Trevi Therapeutics Inc.
• Healio
• Keymed Biosciences Inc.
• MyHealthTeam
• Shanghai SIGMA High-tech Co. Ltd.
• Celgene Corporation
• Dermatology Treatment and Research Center
• Hightower Clinical
• Celldex Therapeutics Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

• 결절성 양진 치료 시장, 2029년 : 새로운 기회를 제공하는 국가
• 결절성 양진 치료 시장, 2029년 : 새로운 기회를 제공하는 부문
• 결절성 양진 치료 시장, 2029년 : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Prurigo nodularis treatment involves various medical approaches aimed at relieving the persistent itching and skin lesions associated with this inflammatory condition. The primary goal is to break the cycle of scratching that worsens the symptoms. Treatment focuses on soothing itching, promoting the healing of nodules, and improving the overall well-being of the patient.

The main types of prurigo nodularis treatment include medications, cryotherapy, phototherapy, pulsed dye laser, and other therapies. Medications are used to alleviate itching, reduce inflammation, and modulate the immune response. Diagnosis typically involves skin biopsies, blood tests, and other methods. Treatments are administered through various routes, including topical, oral, and parenteral administration. These treatments are distributed through multiple channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by different end-users, including clinics, hospitals, and others.

The prurigo nodularis treatment market research report is one of a series of new reports from The Business Research Company that provides prurigo nodularis treatment market statistics, including the prurigo nodularis treatment industry global market size, regional shares, competitors with the prurigo nodularis treatment market share, detailed prurigo nodularis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the prurigo nodularis treatment industry. This prurigo nodularis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The prurigo nodularis treatment market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.73 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period can be attributed to increased investment in dermatology research, a rising demand for personalized medicine, a growing pipeline of novel therapies, more regulatory approvals for treatment options, and an increased use of teledermatology services.

The prurigo nodularis treatment market size is expected to see strong growth in the next few years. It will grow to $2.11 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth during the forecast period can be attributed to increasing healthcare expenditure, rising awareness of prurigo nodularis, a growing demand for targeted therapies, an increase in research and development activities, and more approvals of novel treatments. Key trends in the forecast period include advancements in biologic therapies, improved diagnostic approaches for skin conditions, innovations in topical treatment formulations, integration of teledermatology services, and the development of advanced patient-centric care models.

The increasing prevalence of chronic skin conditions is expected to drive the growth of the prurigo nodularis treatment market in the coming years. Chronic skin conditions are long-term or recurring skin disorders that often require ongoing management and can significantly impact a person's quality of life. The rise in these conditions is attributed to higher exposure to environmental pollutants, which can damage the skin's natural barrier and cause persistent inflammation. Prurigo nodularis treatments focus on addressing the underlying causes of chronic skin conditions by targeting inflammatory pathways responsible for ongoing itching and skin lesions. By regulating immune system overactivity, these therapies effectively alleviate symptoms and improve quality of life for patients with prurigo nodularis. For example, in July 2023, the Office of Health Economics (OHE), a UK-based charity, reported that hidradenitis suppurativa (HS), a painful chronic skin disease, affects at least 200,000 people in the UK, with an estimated economic impact of £3.83 billion ($4.35 billion) annually. Therefore, the increasing incidence of chronic skin conditions is contributing to the growth of the prurigo nodularis treatment market.

Leading companies in the prurigo nodularis treatment market are concentrating on developing innovative therapies, including monoclonal antibodies, which aim to target specific immune pathways and offer more effective symptom relief. Monoclonal antibodies are synthetic molecules designed to replicate the immune system's natural ability to combat harmful pathogens including viruses. For example, in August 2024, the Switzerland-based pharmaceutical company Galderma announced that the U.S. Food and Drug Administration (FDA) had approved Nemluvio (nemolizumab) for the treatment of adult patients with prurigo nodularis. This approval followed promising results from the OLYMPIA clinical trials, in which Nemluvio showed notable improvements in itch intensity and skin nodules. The treatment specifically targets IL-31 signaling, which plays a crucial role in driving the symptoms of prurigo nodularis.

In December 2022, MyHealthTeam, a U.S.-based provider of treatment solutions for prurigo nodularis, teamed up with Arcutis Biotherapeutics to introduce MySebDermTeam, a new social platform designed to support individuals living with seborrheic dermatitis. The partnership aims to tackle issues including underdiagnosis and limited access to reliable information, particularly within underserved communities, by providing trusted connections and expert advice to help speed up diagnosis and treatment. Arcutis Biotherapeutics is a US-based biopharmaceutical company focused on developing and commercializing therapies for dermatological conditions.

Major players in the prurigo nodularis treatment market are Roche Holding AG, Sanofi S.A., Amgen Inc., Regeneron Pharmaceuticals Inc., Galderma S.A., Incyte Corporation, LEO Pharma A/S, Almirall S.A., Maruho Co. Ltd., VYNE Therapeutics Inc., Kiniksa Pharmaceuticals Ltd., Trevi Therapeutics Inc., Healio, Keymed Biosciences Inc., MyHealthTeam, Shanghai SIGMA High-tech Co. Ltd., Celgene Corporation, Dermatology Treatment and Research Center, Hightower Clinical, Celldex Therapeutics Inc., Psoriasis Treatment Center of Central New Jersey, and Skin Care Research.

North America was the largest region in the prurigo nodularis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in prurigo nodularis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the prurigo nodularis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prurigo nodularis treatment market consists of revenues earned by entities by providing services such as medical consultation, psychological support, wound care, and bandaging. The market value includes the value of related goods sold by the service provider or included within the service offering. The prurigo nodularis treatment market also includes sales of patch test kits, punch biopsy tools, and injectable monoclonal antibodies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prurigo Nodularis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prurigo nodularis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prurigo nodularis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prurigo nodularis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Medication; Cryotherapy; Phototherapy; Pulsed Dye Laser; Other Treatments
• 2) By Diagnosis: Skin Biopsy; Blood Tests; Other Diagnosis
• 3) By Route Of Administration: Topical Administration; Oral Administration; Parenteral Administration
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End-Users: Clinic; Hospital; Other End-Users
• Subsegments:
• 1) By Medication: Topical Corticosteroids; Antihistamines; Immunosuppressants; Neuromodulators; Biologic Therapies
• 2) By Cryotherapy: Liquid Nitrogen Application; Spray-Freezing Techniques; Cryoprobe Therapy
• 3) By Phototherapy: Narrowband Ultraviolet B (NB-UVB); Broadband Ultraviolet B (BB-UVB); Psoralen Plus Ultraviolet A (PUVA)
• 4) By Pulsed Dye Laser: 585 Nanometer (nm) Wavelength Therapy; 595 Nanometer (nm) Wavelength Therapy
• 5) By Other Treatments: Behavioral Therapy; Acupuncture; Emollients and Moisturizers; Surgical Excision
• Companies Mentioned: Roche Holding AG; Sanofi S.A.; Amgen Inc.; Regeneron Pharmaceuticals Inc.; Galderma S.A
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prurigo Nodularis Treatment Market Characteristics

3. Prurigo Nodularis Treatment Market Trends And Strategies

4. Prurigo Nodularis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Prurigo Nodularis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Prurigo Nodularis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Prurigo Nodularis Treatment Market Growth Rate Analysis
• 5.4. Global Prurigo Nodularis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Prurigo Nodularis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Prurigo Nodularis Treatment Total Addressable Market (TAM)

6. Prurigo Nodularis Treatment Market Segmentation

• 6.1. Global Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Cryotherapy
• Phototherapy
• Pulsed Dye Laser
• Other Treatments
• 6.2. Global Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Skin Biopsy
• Blood Tests
• Other Diagnosis
• 6.3. Global Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Administration
• Oral Administration
• Parenteral Administration
• 6.4. Global Prurigo Nodularis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Prurigo Nodularis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinic
• Hospital
• Other End-Users
• 6.6. Global Prurigo Nodularis Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Corticosteroids
• Antihistamines
• Immunosuppressants
• Neuromodulators
• Biologic Therapies
• 6.7. Global Prurigo Nodularis Treatment Market, Sub-Segmentation Of Cryotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Nitrogen Application
• Spray-Freezing Techniques
• Cryoprobe Therapy
• 6.8. Global Prurigo Nodularis Treatment Market, Sub-Segmentation Of Phototherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Narrowband Ultraviolet B (NB-UVB)
• Broadband Ultraviolet B (BB-UVB)
• Psoralen Plus Ultraviolet A (PUVA)
• 6.9. Global Prurigo Nodularis Treatment Market, Sub-Segmentation Of Pulsed Dye Laser, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 585 Nanometer (nm) Wavelength Therapy
• 595 Nanometer (nm) Wavelength Therapy
• 6.10. Global Prurigo Nodularis Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Behavioral Therapy
• Acupuncture
• Emollients and Moisturizers
• Surgical Excision

7. Prurigo Nodularis Treatment Market Regional And Country Analysis

• 7.1. Global Prurigo Nodularis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Prurigo Nodularis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prurigo Nodularis Treatment Market

• 8.1. Asia-Pacific Prurigo Nodularis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prurigo Nodularis Treatment Market

• 9.1. China Prurigo Nodularis Treatment Market Overview
• 9.2. China Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prurigo Nodularis Treatment Market

• 10.1. India Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prurigo Nodularis Treatment Market

• 11.1. Japan Prurigo Nodularis Treatment Market Overview
• 11.2. Japan Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prurigo Nodularis Treatment Market

• 12.1. Australia Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prurigo Nodularis Treatment Market

• 13.1. Indonesia Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prurigo Nodularis Treatment Market

• 14.1. South Korea Prurigo Nodularis Treatment Market Overview
• 14.2. South Korea Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prurigo Nodularis Treatment Market

• 15.1. Western Europe Prurigo Nodularis Treatment Market Overview
• 15.2. Western Europe Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prurigo Nodularis Treatment Market

• 16.1. UK Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prurigo Nodularis Treatment Market

• 17.1. Germany Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prurigo Nodularis Treatment Market

• 18.1. France Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prurigo Nodularis Treatment Market

• 19.1. Italy Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prurigo Nodularis Treatment Market

• 20.1. Spain Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prurigo Nodularis Treatment Market

• 21.1. Eastern Europe Prurigo Nodularis Treatment Market Overview
• 21.2. Eastern Europe Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prurigo Nodularis Treatment Market

• 22.1. Russia Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prurigo Nodularis Treatment Market

• 23.1. North America Prurigo Nodularis Treatment Market Overview
• 23.2. North America Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prurigo Nodularis Treatment Market

• 24.1. USA Prurigo Nodularis Treatment Market Overview
• 24.2. USA Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prurigo Nodularis Treatment Market

• 25.1. Canada Prurigo Nodularis Treatment Market Overview
• 25.2. Canada Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prurigo Nodularis Treatment Market

• 26.1. South America Prurigo Nodularis Treatment Market Overview
• 26.2. South America Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prurigo Nodularis Treatment Market

• 27.1. Brazil Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prurigo Nodularis Treatment Market

• 28.1. Middle East Prurigo Nodularis Treatment Market Overview
• 28.2. Middle East Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prurigo Nodularis Treatment Market

• 29.1. Africa Prurigo Nodularis Treatment Market Overview
• 29.2. Africa Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prurigo Nodularis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Prurigo Nodularis Treatment Market Competitive Landscape
• 30.2. Prurigo Nodularis Treatment Market Company Profiles
  • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Galderma S.A Overview, Products and Services, Strategy and Financial Analysis

31. Prurigo Nodularis Treatment Market Other Major And Innovative Companies

• 31.1. Incyte Corporation
• 31.2. LEO Pharma A/S
• 31.3. Almirall S.A.
• 31.4. Maruho Co. Ltd.
• 31.5. VYNE Therapeutics Inc.
• 31.6. Kiniksa Pharmaceuticals Ltd.
• 31.7. Trevi Therapeutics Inc.
• 31.8. Healio
• 31.9. Keymed Biosciences Inc.
• 31.10. MyHealthTeam
• 31.11. Shanghai SIGMA High-tech Co. Ltd.
• 31.12. Celgene Corporation
• 31.13. Dermatology Treatment and Research Center
• 31.14. Hightower Clinical
• 31.15. Celldex Therapeutics Inc.

32. Global Prurigo Nodularis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prurigo Nodularis Treatment Market

34. Recent Developments In The Prurigo Nodularis Treatment Market

35. Prurigo Nodularis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Prurigo Nodularis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Prurigo Nodularis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Prurigo Nodularis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료